News | November 01, 2021
GlaxoSmithKline posts Q2FY22 consolidated PAT at Rs. 204.24 Cr
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
The company is a medical dictation solution used by medical practitioners
Clear aligners are a series of tight-fitting custom-made mouthpieces or orthodontic systems that are useful in correcting misaligned or crooked teeth
Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 3rd December 2021 for a start of procedure in 2021
It provides an option to automatically perform nodule detection immediately after chest X-ray imaging
_256_384.jpg)
Both parties are expected to invest a total of US $ 1 million to establish the brand
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
The NFI is published to promote the rational use of medicines in the country.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
